DITOXO is a dual-arch intraoral scanner that captures the maxillary and mandibular arches simultaneously inside a calibrated, bite-stabilized geometry — so the occlusal relationship is measured, not reconstructed.
Every design decision in DITOXO traces back to capturing both arches and their true relationship in one optical pass — cleanly, repeatably, and inside the operatory workflow.
Both arches are recorded optically in a single pass, preserving their true spatial relationship instead of stitching two separate scans.
A fixed reference frame with a characterized sensor geometry holds the arches in one coordinate system throughout the capture.
Because both arches share one frame from the start, the occlusal relationship is measured directly rather than reconstructed by software.
Patient-contacting components are engineered for single-use barriers and a reprocessable assembly, built around operatory hygiene protocols.
Output is designed for open mesh formats (STL / PLY / OBJ) and DICOM, so captures move into existing CAD/CAM, PACS, and practice systems.
A companion platform for reviewing, annotating, and securely sharing dual-arch captures across the care team.
A traditional wand builds a model by weaving thousands of frames together in real time. That weaving is where the heavy compute load and the accuracy drift come from — and it happens again, separately, to relate the two arches. DITOXO captures inside a fixed geometry, so alignment is solved once, in hardware.
// Conceptual comparison of capture approaches. DITOXO is in development; the degree of on-device alignment depends on the final sensor architecture.
The upper arch is captured optically in the same pass as the lower — no separate exposure, no separate setup. Both arches enter one coordinate frame from the first frame of data.
Apply the single-use barrier and seat the patient — one setup, both arches.
The bite-stabilized frame engages, fixing the inter-arch relationship.
A single optical pass records both arches inside the calibrated geometry.
The mesh / DICOM dataset lands in your software — or in DITOXO Studio.
Current engineering design targets for each product in the DITOXO line. Final specifications will be confirmed through verification and validation as part of the regulatory submission.
// Targets shown are provisional and subject to change.
// DITOXO is an investigational device — not yet cleared by the U.S. FDA.
The conventional workflow scans each arch separately and reconstructs the occlusion. DITOXO is designed to collapse that into a single, measured acquisition.
Intended uses will be finalized as part of the regulatory submission.
A faster routine capture of both arches and the bite for documentation and chairside review.
A measured inter-arch relationship to support treatment planning and progress comparison.
A unified dual-arch mesh designed to flow into restorative design and milling workflows.
A consistent, repeatable capture useful for teaching, case libraries, and review.
One-pass acquisition designed to keep throughput high without sacrificing completeness.
Open-format output and Studio sharing built to move captures securely between sites.
Odonteikon is engaging clinical, commercial, and technology partners as the platform advances toward submission and launch.
Practitioners and institutions shaping intended use, workflow fit, and future evaluation.
Channel partners positioned to bring a cleared DITOXO line to dental markets.
Software, optics, and manufacturing collaborators across the development pipeline.
DITOXO targets a specific, defensible problem: capturing both arches and their true relationship in a single pass — protected by pending IP and built for the established 510(k) pathway.
A calibrated, bite-stabilized geometry that measures the occlusal relationship rather than reconstructing it — the core of the platform's value.
The dual-arch acquisition method and apparatus are the subject of a pending U.S. patent application.
Development is structured for the FDA 510(k) premarket notification pathway, under a documented design-control process.
A dental-imaging company carrying DITOXO through patent, regulatory submission, and commercialization.
The dual-arch acquisition method was conceived and reduced to a working design concept by founder and inventor Jeffrey D. Retherford.
A U.S. patent application covering the dual-arch acquisition method and apparatus was filed (App. No. 64/060,672, May 8, 2026).
System design and manufacturing documentation are being developed under formal revision control as the platform matures.
Bench testing and validation to confirm the scanner meets its design targets and intended-use requirements.
Preparation and submission of the 510(k) premarket notification to the U.S. FDA.
Following clearance, commercial availability of the full DITOXO line — One, Studio, and Care.
// This page is informational only and does not constitute an offer to sell, or a solicitation of an offer to buy, any security. DITOXO is an investigational device and has not been cleared or approved by the U.S. FDA.
Periodic updates on DITOXO's progress toward clearance. Forward-looking by nature and subject to change.
A U.S. patent application covering the dual-arch acquisition method and apparatus was filed, establishing patent-pending status for the platform's core geometry.
System design and manufacturing documentation moved under formal revision control, the backbone of a 510(k)-ready quality process.
The calibrated, bite-stabilized acquisition approach was set, anchoring the measured-occlusion design that distinguishes DITOXO.
Work is focused on bench verification and validation ahead of the planned FDA 510(k) submission.
A dual-arch intraoral scanner: it captures the upper and lower dental arches optically in a single pass, inside a calibrated, bite-stabilized geometry that records the occlusal relationship as a measured quantity.
Conventional intraoral scanning captures each arch separately and reconstructs the bite in software from a separate scan. DITOXO holds both arches in one coordinate frame and captures them together, so the relationship is measured rather than estimated.
No. DITOXO is in active development and is being evaluated through the FDA 510(k) pathway. It has not been cleared or approved and is not available for sale or clinical use in the United States.
Output is being designed for open mesh formats (STL / PLY / OBJ) and DICOM, so captures flow into existing CAD/CAM, PACS, and practice-management systems. DITOXO Studio adds review, annotation, and secure sharing.
Odonteikon Corporation, a dental-imaging company based in Grand Rapids, Michigan, founded by inventor Jeffrey D. Retherford.
Investors can request diligence at investors@odonteikon.com; clinical and commercial partners can reach partnerships at partners@odonteikon.com.
Odonteikon is a Grand Rapids–based dental-imaging company building the next generation of chairside capture. We design hardware that removes steps from the clinical workflow — and we carry it through the full arc of patent, regulatory submission, and commercialization.
DITOXO is our first platform: a dual-arch intraoral scanner created to capture both arches, and their true relationship, in a single pass.
Tell us a little about you and we'll follow up with current development status and the right next step.